sn 23862 has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ay, M; Çelik, A; Gülhan, ÜG; Güngör, T; Hacıoğlu, N; Köçkar, F; Önder, FC; Tok, TT; Tokay, E | 1 |
1 other study(ies) available for sn 23862 and Prostatic Neoplasms
| Article | Year |
|---|---|
Prodrugs for nitroreductase-based cancer therapy-3: Antitumor activity of the novel dinitroaniline prodrugs/Ssap-NtrB enzyme suicide gene system: Synthesis, in vitro and in silico evaluation in prostate cancer.
Topics: Aniline Compounds; Antineoplastic Agents; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Genetic Therapy; Humans; Male; Models, Molecular; Molecular Structure; Nitroreductases; Prodrugs; Prostatic Neoplasms; Structure-Activity Relationship | 2020 |